Atherogenics Switches Focus For AGI-1067 To Glycemic Control In Diabetes
This article was originally published in The Pink Sheet Daily
Executive Summary
Atherogenics will begin looking for a new partner for the former atherosclerosis treatment, firm tells “The Pink Sheet” DAILY.